Cargando…

Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass

A treatment strategy of a difficult and unusual problem is presented. We are reporting a case of a patient who had a documented allergy to heparin and required Cardiac surgery for an ASD closure. The anticoagulation regime used during cardiopulmonary bypass was lepirudin based. This report indicates...

Descripción completa

Detalles Bibliográficos
Autor principal: Parissis, Haralabos
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079612/
https://www.ncbi.nlm.nih.gov/pubmed/21477293
http://dx.doi.org/10.1186/1749-8090-6-44
_version_ 1782202028079972352
author Parissis, Haralabos
author_facet Parissis, Haralabos
author_sort Parissis, Haralabos
collection PubMed
description A treatment strategy of a difficult and unusual problem is presented. We are reporting a case of a patient who had a documented allergy to heparin and required Cardiac surgery for an ASD closure. The anticoagulation regime used during cardiopulmonary bypass was lepirudin based. This report indicates that r-hirudin provides effective anticoagulation, however unless ECT is monitoring, post operative hemorrhage is encountered. Therefore this case is unique not only because of its rarity but also by the fact that it presents the caveats encountered when ECT is not available.
format Text
id pubmed-3079612
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30796122011-04-20 Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass Parissis, Haralabos J Cardiothorac Surg Case Report A treatment strategy of a difficult and unusual problem is presented. We are reporting a case of a patient who had a documented allergy to heparin and required Cardiac surgery for an ASD closure. The anticoagulation regime used during cardiopulmonary bypass was lepirudin based. This report indicates that r-hirudin provides effective anticoagulation, however unless ECT is monitoring, post operative hemorrhage is encountered. Therefore this case is unique not only because of its rarity but also by the fact that it presents the caveats encountered when ECT is not available. BioMed Central 2011-04-08 /pmc/articles/PMC3079612/ /pubmed/21477293 http://dx.doi.org/10.1186/1749-8090-6-44 Text en Copyright ©2011 Parissis; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Parissis, Haralabos
Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass
title Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass
title_full Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass
title_fullStr Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass
title_full_unstemmed Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass
title_short Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass
title_sort lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079612/
https://www.ncbi.nlm.nih.gov/pubmed/21477293
http://dx.doi.org/10.1186/1749-8090-6-44
work_keys_str_mv AT parissisharalabos lepirudinasanalternativetoheparinallergyduringcardiopulmonarybypass